Donyai Parastou, McCrindle Rachel, Hui Terence K L, Sherratt R Simon
Reading School of Pharmacy, University of Reading, P.O. Box 226, Whiteknights, Reading RG6 6AP, UK.
Department of Biomedical Engineering, School of Biological Sciences, University of Reading, Whiteknights, Reading RG6 6AY, UK.
Pharmacy (Basel). 2021 Apr 16;9(2):85. doi: 10.3390/pharmacy9020085.
People's views about medicines reuse are being examined in a handful of qualitative studies and this commentary adds to that work by drawing on our own discussions with groups of stakeholders in the UK in the past two years. The reuse of medicines within the community pharmacy setting is not permitted in the UK but our multidisciplinary team anticipates that this position will change in the coming years as medication shortages and worries about environmental waste and financial losses from the destruction of unused medicines are brought to the fore. Indeed, for many stakeholders, the issue of waste is a strong feature of conversations about medicines reuse. In addition to this, stakeholders identify the numerous barriers to medicines reuse in the UK. This includes the current uncertainty about the quality of unused medicines returned to pharmacies, which could otherwise be reused. However, stakeholders have also been very willing to propose solutions to a range of existing barriers. Our commentary draws on stakeholder meetings to elaborate the range of views about medicines reuse within a UK context. The challenge is to move forward from these views to advance the technologies that will facilitate medicines reuse practically as well as legally.
一些定性研究正在考察人们对药品再利用的看法，本评论通过借鉴我们过去两年与英国利益相关者群体的讨论，为这项工作增添了内容。在英国，社区药房环境下不允许药品再利用，但我们的多学科团队预计，随着药品短缺以及对环境废物和未使用药品销毁造成的经济损失的担忧日益凸显，这一立场在未来几年将会改变。事实上，对于许多利益相关者来说，废物问题是药品再利用讨论中的一个突出特点。除此之外，利益相关者还指出了英国药品再利用存在的众多障碍。这包括目前返还给药房的未使用药品质量存在不确定性，否则这些药品本可被再利用。然而，利益相关者也非常愿意为一系列现有障碍提出解决方案。我们的评论借鉴了利益相关者会议，阐述了在英国背景下对药品再利用的各种观点。挑战在于从这些观点出发，推动既能在实际操作上又能在法律上促进药品再利用的技术发展。
